Literature DB >> 4099314

Treatment of corticosteroid-resistant polymyositis with methotrexate.

M C Sokoloff, L S Goldberg, C M Pearson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4099314     DOI: 10.1016/s0140-6736(71)80005-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

Review 1.  Current management of polymyositis and dermatomyositis.

Authors:  C V Oddis; T A Medsger
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

2.  Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung.

Authors:  D Fairlamb; E Boesen
Journal:  Postgrad Med J       Date:  1977-05       Impact factor: 2.401

3.  Lymphocyte sensitivity to human skeletal muscle antigen in polymyositis.

Authors:  M M Esiri; B L Hazleman; I C MacLennan
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

4.  Methotrexate therapy in polymyositis.

Authors:  F C Arnett; J C Whelton; T M Zizic; M B Stevens
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

Review 5.  Recognition and management of myositis.

Authors:  P Cherin
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 6.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

7.  [Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].

Authors:  S Briem; H-M Lorenz
Journal:  Z Rheumatol       Date:  2011-02       Impact factor: 1.372

8.  Polymyositis-dermatomyositis: diagnostic and prognostic significance of muscle alkaline phosphatase.

Authors:  D Cros; C Pearson; M A Verity
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

9.  The treatment of disseminated vasculitis with methotrexate.

Authors:  M S Mitchell; R H Gifford; J R Bertino; J D Kenney; S E Malawista
Journal:  Inflammation       Date:  1976-06       Impact factor: 4.092

10.  [Severe dysphagia and erythrodermia in a 59-year-old man].

Authors:  M A Zuber; M Kouba; S E Rudolph; M Weller; P Hrdlicka
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.